M. Barletta

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

Giacomo Allegrini, Teresa Di Desidero, M. Barletta et al. · Angiogenesis · 2012 · 71 citations · Full text

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients

Giacomo Allegrini, Alfredo Falcone, Antonio Fioravanti et al. · British Journal of Cancer · 2008 · 65 citations · Full text

Discovery, Biological Evaluation, and Structure–Activity and −Selectivity Relationships of 6′-Substituted (<i>E</i>)-2-(Benzofuran-3(2<i>H</i>)-ylidene)-<i>N</i>-methylacetamides, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors

Leonardo Pisani, M. Barletta, Ramón Soto‐Otero et al. · Journal of Medicinal Chemistry · 2013 · 60 citations · Full text

Combinatorial Chemistry, Organic Chemistry, Pharmacotherapy +18

Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9

Orazio Nicolotti, Marco Catto, Ilenia Giangreco et al. · European Journal of Medicinal Chemistry · 2012 · 47 citations · Full text

Medicinal Chemistry, Biochemistry, Natural Sciences +8

The influence of positional isomerism on G-quadruplex binding and anti-proliferative activity of tetra-substituted naphthalene diimide compounds

Sheila Mpima, Stephan A. Ohnmacht, M. Barletta et al. · Bioorganic & Medicinal Chemistry · 2013 · 20 citations

Combinatorial Chemistry, Anti-proliferative Activity, Biochemistry +6